Barriers for the evaluation of advanced therapy medicines and their translation to clinical practice: Umbrella review-Reference-Cited by-同舟云学术

Barriers for the evaluation of advanced therapy medicines and their translation to clinical practice: Umbrella review

Published:2022-12 Issue:12 Volume:126 Page:1248-1255
ISSN:0168-8510
Container-title:Health Policy
language:en
Short-container-title:Health Policy

Author:

Aguilera-Cobos Lorena,Rosario-Lozano María Piedad,Ponce-Polo Angela,Blasco-Amaro Juan Antonio,Epstein David

Publisher

Elsevier BV

Subject

Health Policy

Reference57 articles.

1. Procedural advice on the evaluation of advanced therapy medicinal product in accordance with Article 8 of Regulation (EC) No 1394/2007 [Internet],2018

2. Gene therapy;High;N Engl J Med,2019

3. Comittee for advanced therapies [Internet],2021

4. Growth & resilience in regenerative medicine. Annual report [Internet],2020

5. Getting ready: recommendations for timely access to advanced therapy medicinal products (ATMPs) in Europe. [Internet],2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful transport across continents of GMP-manufactured and cryopreserved culture-expanded human fetal liver-derived mesenchymal stem cells for use in a clinical trial;Regenerative Therapy;2024-06

2. Improving access to gene therapy for rare diseases;Disease Models & Mechanisms;2024-04-19

3. Advanced-Therapy Medicinal Products: Challenges for Implementation in Pediatric Clinical Practice;Current Pediatrics;2024-02-25

4. Navigating Gene Therapy Access: The Case of Bulgaria in the Context of the EU Regulatory Landscape;Healthcare;2024-02-11

5. Pricing and reimbursement mechanisms for advanced therapy medicinal products in 20 countries;Frontiers in Pharmacology;2023-11-28